Tobramycin: Medgend

AKTOB [Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

0.3% (ophthalmic solution/drops)

Akorn^{Jan 31, 1996}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

BETHKIS [Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

300mg/4ml (inhalation solution)

Chiesi Usa Inc^{Oct 12, 2012}

Management of cystic fibrosis patients.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

KITABIS PAK [Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

300mg/5ml (inhalation solution)

Pulmoflow Inc^{Dec 2, 2014}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBI [Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

300mg/5ml (inhalation solution)

Novartis Pharms^{Dec 22, 1997}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBI PODHALER [Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

28mg (inhalation powder)

Novartis^{Mar 22, 2013}

Treatment of cystic fibrosis patients with pseudomonas aeruginosa.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBRADEX [Dexamethasone^{C₂₂H₂₉FO₅} : Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

0.1% : 0.3% (ophthalmic suspension/drops)

Novartis Pharms Corp^{Aug 18, 1988}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBRADEX ST [Dexamethasone^{C₂₂H₂₉FO₅} : Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

0.05% : 0.3% (ophthalmic suspension/drops)

Novartis Pharms Corp^{Feb 13, 2009}

Use of a combination of tobramycin and dexamethasone to treat ocular inflammation where an infection or risk of infection exists.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBRAMYCIN [Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

0.3% (ophthalmic solution/drops)

300mg/5ml (inhalation solution)

Bausch And Lomb^{Nov 29, 1993}
Fera Pharms^{Sep 11, 2001}
Somerset Theraps Llc^{Jun 28, 2017}
Akorn Inc^{May 28, 2014}
Amneal Pharms^{Jul 13, 2015}
Lupin Atlantis^{Mar 22, 2017}
Teva Pharms Usa^{Oct 10, 2013}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBRAMYCIN AND DEXAMETHASONE [Dexamethasone^{C₂₂H₂₉FO₅} : Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

0.1% : 0.3% (ophthalmic suspension/drops)

Bausch And Lomb^{Oct 27, 1999}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBRAMYCIN SULFATE [Tobramycin Sulfate^{2C₁₈H₃₇N₅O₉5H₂O₄S}]

RX

-

eq 1.2gm base/vial (injection injectable)

eq 10mg base/ml (injection injectable)

eq 40mg base/ml (injection injectable)

Fresenius Kabi Usa^{Jul 13, 2004}
X Gen Pharms^{Aug 17, 2001}
Xellia Pharms Aps^{Sep 16, 2014}
Hospira^{Apr 30, 1991}
Akorn^{Sep 16, 2014}
Claris^{Jul 1, 2016}
Mylan Labs Ltd^{Mar 11, 2008}
Teva Pharms Usa^{Jan 30, 1992}
West-ward Pharms Int^{Apr 26, 1991}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBRAMYCIN SULFATE (PHARMACY BULK) [Tobramycin Sulfate^{2C₁₈H₃₇N₅O₉5H₂O₄S}]

RX

-

eq 40mg base/ml (injection injectable)

Fresenius Kabi Usa^{Nov 29, 2002}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER [Tobramycin Sulfate^{2C₁₈H₃₇N₅O₉5H₂O₄S}]

RX

-

eq 1.2mg base/ml (injection injectable)

eq 1.6mg base/ml (injection injectable)

eq 80mg base/100ml (injection injectable)

Hospira^{Jul 31, 1990}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TOBREX [Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

0.3% (ophthalmic solution/drops)

Novartis Pharms Corp^{Approved Prior To Jan 1, 1982}
Sandoz Inc^{Dec 13, 1984}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ZYLET [Loteprednol Etabonate^{C₂₄H₃₁ClO₇} : Tobramycin^{C₁₈H₃₇N₅O₉}]

RX

-

0.5% : 0.3% (ophthalmic suspension/drops)

Bausch And Lomb^{Dec 14, 2004}

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Tobramycin FDA Approved Drugs